paradigm logo NEW

Paradigm Biopharma (ASX: PAR)

Last close As at 28/03/2024

0.46

0.02 (4.55%)

Market capitalisation

AUD154m

Latest Insights

View More

Sector

Healthcare

Balance Sheet

Forecast net debt (A$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 6.3 (26.8) (69.6)
Relative (0.1) (32.6) (72.0)
52 week high/low A$1.5/A$0.4

Financials

Edison Investment Research is terminating coverage on Paradigm Biopharma (PAR). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

 

Previously published reports can still be accessed via our website.

Y/E Jun Revenue (A$m) EBITDA (A$m) PBT (A$m) EPS (fd) (c) P/E (x) P/CF (x)
2022A 0.1 (55.7) (39.2) (16.9) N/A N/A
2023A 0.0 (59.9) (51.9) (21.0) N/A N/A
2024E N/A N/A N/A N/A N/A N/A
2025E N/A N/A N/A N/A N/A N/A

Further insights

insight

Healthcare

Healthcare Week 2023

Analyst of the week

Soo Romanoff

Soo Romanoff

Managing Director - Head of Content, Healthcare

Read latest

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free